Clinical Trials Browser

Phase 3 × OTHER × Melphalan × Clear all

NCT07396480 2026-03-17

Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial

Phase 3 Recruiting

Venentoclax

NCT01208766 2026-01-06

HO95

Phase 3 Completed

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00734877 2025-06-29

TT4B

Phase 3 Active not recruiting

Multiple Myeloma

NCT05991908 2025-02-18

Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies

Phase 3 Recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06829472 2025-02-17

Conditioning Regimen of Melphalan-busulfan and Fludarabine: a Randomized Study of Different Dose of Melphalan

Phase 3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05674539 2025-02-10

Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Phase 3 Enrolling by invitation

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01093196 2024-11-07

Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients

Phase 3 Completed

Disease, Multiple Myeloma

NCT01091831 2024-11-06

Cyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Stem Cell Transplant (ASCT) In Newly Diagnosed Multiple Myeloma Subjects

Phase 3 Completed

Multiple Myeloma

NCT06613035 2024-09-25

Twice-per-weekSelinexor, 2 Days Melphalan

Phase 3 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00551928 2024-07-22

MPRvsMEL200

Phase 3 Completed

Multiple Myeloma

NCT01339910 2023-01-04

BMT CTN 0901

Phase 3 Terminated

272 enrolled 29 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05466318 2022-07-25

ChiCGB vs BEAM in High-risk or R/R Lymphomas

Phase 3 Unknown

Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

NCT02197221 2022-05-23

IFM2014-02

Phase 3 Completed

Multiple Myeloma

NCT04799002 2021-03-16

Topotecan and Melphalan for Retinoblastoma

Phase 3 Recruiting

Other solid neoplasm

Retinoblastoma

NCT01704716 2020-10-23

High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)

Phase 3 Recruiting

Neuroblastoma

NCT01413178 2020-04-21

A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Phase 3 Completed

205 enrolled 11 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00137995 2019-08-28

R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma

Phase 3 Completed

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT02489500 2018-09-10

VelRand

Phase 3 Terminated

3 enrolled 11 charts

Immunoglobulin Light-chain Amyloidosis

NCT01916252 2017-09-27

GEM2012MENOS65

Phase 3 Completed

Multiple Myeloma

NCT00920153 2016-09-16

Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma

Phase 3 Terminated

Hodgkin Disease, Lymphoma

NCT00477971 2016-05-17

Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis

Phase 3 Completed

89 enrolled 11 charts

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Neoplasms, Plasma Cell

NCT00892346 2016-05-10

Single Autologous Stem Cell Transplantation Followed by Maintenance Therapy as Front-line Treatment for Myeloma

Phase 3 Suspended

Multiple Myeloma

NCT00083551 2015-11-23

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy

Phase 3 Completed

668 enrolled 7 charts

Multiple Myeloma, Neoplasms

NCT00217438 2015-08-21

Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma

Phase 3 Completed

130 enrolled 6 charts

Multiple Myeloma

NCT02288741 2014-11-11

DSMM-II

Phase 3 Completed

Multiple Myeloma

NCT01998503 2013-11-29

Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis

Phase 3 Completed

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT00205764 2013-11-25

Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy

Phase 3 Completed

Multiple Myeloma

NCT00004165 2012-06-06

Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Phase 3 Completed

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Neoplasms, Plasma Cell

NCT00003215 2012-05-15

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma

Phase 3 Completed

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

NCT00002945 2012-04-13

High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia

Phase 3 Completed

Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00573391 2011-08-12

Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2

Phase 3 Terminated

5 enrolled 6 charts

Multiple Myeloma

NCT00186966 2011-04-06

Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia

Phase 3 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00008229 2010-09-21

Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Phase 3 Completed

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00003972 2010-04-02

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer

Phase 3 Completed

Breast Neoplasms

NCT01070862 2010-02-18

MAG 2002

Phase 3 Completed

Multiple Myeloma

NCT00644306 2008-03-26

IFM 01/01

Phase 3 Terminated

Multiple Myeloma

NCT00344526 2007-06-28

Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis

Phase 3 Completed

Immunoglobulin Light-chain Amyloidosis